Table of Content

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Key Data from Secondary Sources 19
2.1.2 PRIMARY DATA 20
2.1.2.1 Key Data from Primary Sources 21
2.1.2.2 Key Industry Insights 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 22
2.2.2 TOP-DOWN APPROACH 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 30
4.1 HEALTHCARE DISTRIBUTION SERVICES: MARKET OVERVIEW 30
4.2 NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE (2018) 31
4.3 EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER (2018) 32
4.4 HEALTHCARE DISTRIBUTION SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS 34
5.2.1 DRIVERS 35
5.2.1.1 High incidence and large economic burden of chronic diseases 35
5.2.1.2 Favorable R&D investment scenario and subsequent increase in drug launches 35
5.2.1.3 Growth of track & trace solutions 36
5.2.1.4 Growing importance of generics 38
5.2.1.5 Growth of the medical devices industry 38
5.2.2 OPPORTUNITIES 39
5.2.2.1 Growth in the biosimilars market 39
5.2.2.2 Emerging markets 39
5.2.2.3 Increasing specialty drug dispensing 40
5.2.2.4 Increasing uptake of biopharmaceuticals 40
5.2.3 CHALLENGES 42
5.2.3.1 Pricing pressures 42

6 HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 43
6.1 INTRODUCTION 44
6.2 PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES 45
6.2.1 OVER-THE-COUNTER DRUGS/VITAMINS 46
6.2.1.1 Sales of OTC drugs have risen due to innovations, promotion of self-medication, and increased access 46
6.2.2 BRAND-NAME/INNOVATOR DRUGS 47
6.2.2.1 Rising demand for prescription drugs to support the growth of this market segment 47
6.2.3 GENERIC DRUGS 48
6.2.3.1 Government initiatives for promoting the usage of generics to support the growth of this market segment 48
6.3 MEDICAL DEVICE DISTRIBUTION SERVICES 49
6.4 BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES 50
6.4.1 MONOCLONAL ANTIBODIES 52
6.4.1.1 Increasing incidence of cancer to support the growth of this market segment 52
6.4.2 VACCINES 53
6.4.2.1 Growing prevalence of infectious diseases has boosted vaccine development 53
6.4.3 RECOMBINANT PROTEINS 54
6.4.3.1 Growing applications of recombinant proteins in biopharmaceuticals to drive the growth of this market segment 54
6.4.4 BLOOD AND BLOOD PRODUCTS 55
6.4.4.1 Increasing number of blood donations and blood transfusions to support the growth of this market segment 55
6.4.5 OTHER PRODUCTS 56

7 HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 58
7.1 INTRODUCTION 59
7.2 RETAIL PHARMACIES 60
7.2.1 LARGE VOLUME OF PRESCRIPTIONS TO INCREASE THE DEMAND FOR HEALTHCARE DISTRIBUTION SERVICES 60
7.3 HOSPITAL PHARMACIES 61
7.3.1 SIGNIFICANT NUMBER OF INPATIENT VISITS AND REQUIREMENT OF LARGE VOLUME OF DRUGS BY HOSPITALS TO DRIVE THE HEALTHCARE DISTRIBUTION SERVICES MARKET FOR HOSPITAL PHARMACIES 61
7.4 OTHER END USERS 62

8 HEALTHCARE DISTRIBUTION SERVICES MARKET, BY REGION 64
8.1 INTRODUCTION 65
8.2 NORTH AMERICA 66
8.2.1 US 70
8.2.1.1 US dominates the North American healthcare distribution services market 70
8.2.2 CANADA 73
8.2.2.1 Rising prevalence of chronic diseases and increasing market for specialty drugs will drive market growth in Canada 73
8.3 EUROPE 76
8.3.1 GERMANY 80
8.3.1.1 Germany accounted for the largest share of the European healthcare distribution services market in 2018 80
8.3.2 FRANCE 83
8.3.2.1 Presence of leading pharmaceutical companies in the country will drive market growth in France 83
8.3.3 UK 85
8.3.3.1 Growth in the pharmaceuticals market and increase in research activity will drive market growth in the UK 85
8.3.4 REST OF EUROPE 87
8.4 ASIA PACIFIC 90
8.4.1 CHINA AND INDIA ARE THE FASTEST-GROWING MARKETS IN THE APAC 90
8.5 REST OF THE WORLD 94

9 COMPETITIVE LANDSCAPE 98
9.1 INTRODUCTION 98
9.2 HEALTHCARE DISTRIBUTION SERVICES MARKET SHARE ANALYSIS (2018) 98
9.3 COMPETITIVE SCENARIO 100
?

10 COMPANY PROFILES 102
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
10.1 MCKESSON CORPORATION 102
10.2 CARDINAL HEALTH, INC. 107
10.3 AMERISOURCEBERGEN CORPORATION 110
10.4 OWENS & MINOR, INC. 115
10.5 MORRIS & DICKSON CO. L.L.C. 117
10.6 CURASCRIPT SPECIALTY DISTRIBUTION 118
10.7 FFF ENTERPRISES, INC. 119
10.8 MEDLINE INDUSTRIES 120
10.9 ATTAIN MED, INC. 124
10.10 DAKOTA DRUG 125
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

11 APPENDIX 126
11.1 DISCUSSION GUIDE: HEALTHCARE DISTRIBUTION SERVICES MARKET 126
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 129
11.3 AVAILABLE CUSTOMIZATIONS 131
11.4 RELATED REPORTS 131
11.5 AUTHOR DETAILS 132



List of Figures



FIGURE 1 HEALTHCARE DISTRIBUTION SERVICES MARKET SEGMENTATION 15
FIGURE 2 HEALTHCARE DISTRIBUTION SERVICES MARKET: RESEARCH METHODOLOGY 17
FIGURE 3 RESEARCH DESIGN 18
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 20
FIGURE 5 DATA TRIANGULATION METHODOLOGY 24
FIGURE 6 HEALTHCARE DISTRIBUTION SERVICES MARKET SHARE, BY TYPE, 2018 26
FIGURE 7 PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET SHARE BY TYPE, 2018 27
FIGURE 8 BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET SHARE BY TYPE, 2018 27
FIGURE 9 HEALTHCARE DISTRIBUTION SERVICES MARKET SHARE, BY END USER, 2018 28
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE HEALTHCARE DISTRIBUTION SERVICES MARKET 29
FIGURE 11 RISING INCIDENCE OF CHRONIC DISEASES AND AVAILABILITY OF R&D INVESTMENTS ARE THE KEY FACTORS DRIVING MARKET GROWTH 30
FIGURE 12 PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES SEGMENT DOMINATED THE NORTH AMERICAN HEALTHCARE DISTRIBUTION SERVICES MARKET IN 2018 31
FIGURE 13 RETAIL PHARMACIES ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN HEALTHCARE DISTRIBUTION SERVICES MARKET IN 2018 32
FIGURE 14 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 33
FIGURE 15 MEDICAL DEVICES MARKET, 2016–2020 (USD BILLION) 39
FIGURE 16 HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2019 VS. 2024 (USD BILLION) 44
FIGURE 17 HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2019 VS. 2024 (USD BILLION) 59
FIGURE 18 HEALTHCARE DISTRIBUTION SERVICES MARKET: GEOGRAPHIC SNAPSHOT 65
FIGURE 19 NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET SNAPSHOT 67
FIGURE 20 EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET SNAPSHOT 77
FIGURE 21 Y-O-Y GROWTH IN THE GERMAN PHARMACEUTICAL INDUSTRY, 2011–2015 81
FIGURE 22 ASIA PACIFIC: MARKET SNAPSHOT 91
FIGURE 23 ROW: MARKET SNAPSHOT 95
FIGURE 24 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 98
FIGURE 25 MCKESSON CORPORATION: COMPANY SNAPSHOT (2018) 102
FIGURE 26 CARDINAL HEALTH: COMPANY SNAPSHOT (2018) 107
FIGURE 27 AMERISOURCEBERGEN CORPORATION: COMPANY SNAPSHOT (2017) 110
FIGURE 28 OWENS & MINOR: COMPANY SNAPSHOT (2017) 115

 

List of Tables



TABLE 1 SERIALIZATION & AGGREGATION REGULATIONS, BY COUNTRY/REGION 37
TABLE 2 HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 44
TABLE 3 PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 45
TABLE 4 PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY COUNTRY, 2017–2024 (USD BILLION) 46
TABLE 5 PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR OTC DRUGS/VITAMINS, BY COUNTRY, 2017–2024 (USD BILLION) 47
TABLE 6 PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR BRAND-NAME/INNOVATOR DRUGS, BY COUNTRY, 2017–2024 (USD BILLION) 48
TABLE 7 PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR GENERIC DRUGS, BY COUNTRY, 2017–2024 (USD BILLION) 49
TABLE 8 MEDICAL DEVICE DISTRIBUTION SERVICES MARKET, BY COUNTRY 2017–2024 (USD BILLION) 50
TABLE 9 BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 51
TABLE 10 BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY COUNTRY, 2017–2024 (USD BILLION) 51
TABLE 11 BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017–2024 (USD BILLION) 52
TABLE 12 BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR VACCINES, BY COUNTRY, 2017–2024 (USD BILLION) 53
TABLE 13 BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR RECOMBINANT PROTEINS, BY COUNTRY, 2017–2024 (USD BILLION) 54
TABLE 14 BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR BLOOD AND BLOOD PRODUCTS, BY COUNTRY, 2017–2024 (USD BILLION) 55
TABLE 15 BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2017–2024 (USD BILLION) 57
TABLE 16 HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2017–2024 (USD BILLION) 59
TABLE 17 HEALTHCARE DISTRIBUTION SERVICES MARKET FOR RETAIL PHARMACIES BY COUNTRY, 2017–2024 (USD BILLION) 60
TABLE 18 HEALTHCARE DISTRIBUTION SERVICES MARKET FOR HOSPITAL PHARMACIES BY COUNTRY, 2017–2024 (USD BILLION) 61
TABLE 19 HEALTHCARE DISTRIBUTION SERVICES MARKET FOR OTHER END USERS BY COUNTRY, 2017–2024 (USD BILLION) 63
TABLE 20 HEALTHCARE DISTRIBUTION SERVICES MARKET, BY REGION 2017–2024 (USD BILLION) 66
TABLE 21 NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET BY COUNTRY, 2017–2024 (USD BILLION) 68
TABLE 22 NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET BY END USER, 2017–2024 (USD BILLION) 68
TABLE 23 NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 69
TABLE 24 NORTH AMERICA: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017–2024 (USD BILLION) 69
TABLE 25 NORTH AMERICA: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017–2024 (USD BILLION) 70
TABLE 26 US: PHARMACEUTICAL IMPORTS AND EXPORTS (2015) 71
TABLE 27 US: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2017–2024 (USD BILLION) 71
TABLE 28 US: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 72
TABLE 29 US: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 72
TABLE 30 US: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 73
TABLE 31 CANADA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2017–2024 (USD BILLION) 74
TABLE 32 CANADA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 74
TABLE 33 CANADA: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 75
TABLE 34 CANADA: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 75
TABLE 35 EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY COUNTRY 2017–2024 (USD BILLION) 78
TABLE 36 EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2017–2024 (USD BILLION) 78
TABLE 37 EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 79
TABLE 38 EUROPE: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 79
TABLE 39 EUROPE: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 80
TABLE 40 GERMANY: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2017–2024 (USD BILLION) 81
TABLE 41 GERMANY: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 82
TABLE 42 GERMANY: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 82
TABLE 43 GERMANY: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 83
TABLE 44 FRANCE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2017–2024 (USD BILLION) 84
TABLE 45 FRANCE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 84
TABLE 46 FRANCE: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 84
TABLE 47 FRANCE: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 85
TABLE 48 UK: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2017–2024 (USD BILLION) 86
TABLE 49 UK: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 86
TABLE 50 UK: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 86
TABLE 51 UK: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 87
TABLE 52 ROE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2017–2024 (USD BILLION) 88
TABLE 53 ROE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 88
TABLE 54 ROE: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 89
TABLE 55 ROE: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 89
TABLE 56 ASIA PACIFIC: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017–2024 (USD BILLION) 92
TABLE 57 ASIA PACIFIC: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 92
TABLE 58 ASIA PACIFIC: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 93
TABLE 59 ASIA PACIFIC: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017–2024 (USD BILLION) 93
TABLE 60 ROW: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER 2017–2024 (USD BILLION) 96
TABLE 61 ROW: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE 2017–2024 (USD BILLION) 96
TABLE 62 ROW: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 97
TABLE 63 ROW: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET BY TYPE, 2017–2024 (USD BILLION) 97
TABLE 64 SOLUTION AND SERVICE LAUNCHES, 2016–2019 100
TABLE 65 AGREEMENTS, COLLABORATIONS, AND CONTRACTS, 2016–2019 100
TABLE 66 ACQUISITIONS, 2016–2019 101
TABLE 67 EXPANSIONS, 2016–2019 101